The Microbiology of Community-acquired Peritonitis in Children

Romain Dumont1, Raphaël Cinotti, Corinne Lejus

  • 1CHU Nantes, Pôle Anesthésie-Réanimation, Service d'Anesthésie-Réanimation, Nantes, France.

Insights

Pediatric community-acquired peritonitis (CAP) primarily involves Escherichia coli and anaerobes, similar to adults. Amoxicillin-clavulanate shows good susceptibility, but amoxicillin resistance in E. coli is a risk factor for postoperative peritonitis.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Surgical Infections

Background:

  • Limited microbiologic data exists for pediatric community-acquired peritonitis (CAP).
  • Understanding the causative pathogens and their antimicrobial susceptibility is crucial for effective treatment.

Purpose of the Study:

  • To analyze the microbiologic spectrum and antimicrobial susceptibility patterns of pathogens causing pediatric CAP.
  • To identify risk factors associated with postoperative peritonitis in children.

Main Methods:

  • A 2-year retrospective single-center study included children undergoing surgery for CAP.
  • Microbiologic cultures and antimicrobial susceptibility testing of peritoneal isolates were performed.
  • Statistical analysis identified independent risk factors for postoperative peritonitis.

Main Results:

  • Escherichia coli was the predominant aerobic isolate (51%), with 54.8% susceptible to amoxicillin and 90.3% to amoxicillin-clavulanate.
  • Anaerobes constituted 29% of isolates, showing high susceptibility to amoxicillin-clavulanate (94.3%).
  • Amoxicillin or amoxicillin-clavulanate resistant E. coli was the sole independent risk factor for postoperative peritonitis.

Conclusions:

  • The microbiology of pediatric CAP mirrors adult CAP, with a predominance of E. coli and anaerobes.
  • Amoxicillin-clavulanate is effective against common pediatric CAP pathogens.
  • Antibiotic resistance in E. coli is a significant risk factor for adverse outcomes in pediatric CAP.
Abstract

Related Concept Videos

Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...